MannKind Corporation (MNKD) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $1.31B and a free-cash-flow yield of 1.1%. Over the most recent reported fiscal year, revenue grew 22.2% and free cash flow per share fell 62.3%.